Evidence map›Paper›PMID 22777707›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2012

Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cells.

Erik C Dreaden, Sandra C Mwakwari, Lauren A Austin, Matthew J Kieffer, Adegboyega K Oyelere, Mostafa A El-Sayed

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Tailoring Materials for Modulation of Macrophage Fate.Advanced materials (Deerfield Beach, Fla.) · 2021
    Review
  8. Article
  9. Article
  10. Green synthesis of gold nanoparticles usingInternational journal of nanomedicine · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Engineering nanolayered particles for modular drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Review
  17. Article
  18. Article
  19. Review
  20. P-glycoprotein-dependent trafficking of nanoparticle-drug conjugates.Small (Weinheim an der Bergstrasse, Germany) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Erik C DreadenLaser Dynamics Laboratory, Department of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, GA 30332-0400, USA.
Sandra C Mwakwari
Lauren A Austin
Matthew J Kieffer
Adegboyega K Oyelere
Mostafa A El-Sayed

Funding

Toxicity and Efficacy of Gold Nanoparticle Photothermal Therapy in CancerU01CA151802 · NCI · EMORY UNIVERSITY · PI EL-SAYED, MOSTAFA A, SHIN, DONG M · 2010 to 2014
$2.1M
Nonpeptide macrocyclic histone deacetylase (HDAC) inhibitors for targeted lung caR01CA131217 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI OYELERE, ADEGBOYEGA · 2009 to 2013
$1.5M
NCI NIH HHS 1U01CA151802-01NCI NIH HHS R01 CA131217NCI NIH HHS R01CA131217NCI NIH HHS U01 CA151802
6 · The paper itself

Abstract

Gold nanoparticles are known to activate anti-tumor potential in macrophage immune cells; however, the subsequent effects of these cells on others nearby are poorly understood. A novel gold-nanoparticle conjugate that selectively targets and induces cytotoxic activity of tumor-associated macrophages towards breast cancer cells in co-culture is synthesized. These constructs are promising new tools for studying fundamental biological interactions with nanoscale materials and candidates for emerging macrophage-mediated delivery applications.

Indexed as

Cytotoxicity, ImmunologicAnimalsBreast NeoplasmsCell DeathFemaleGoldMacrolidesMacrophagesMetal NanoparticlesMiceNanotubesPhagocytosisTumor Cells, CulturedGoldMacrolides

Identifiers

PMID22777707
PMCPMC3459581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.